TECHNESCAN HDP

This brand name is authorized in United States. It is also authorized in Austria, Estonia, France, Hong Kong SAR China, Ireland, Romania, Singapore, Spain, UK.

Active ingredients

The drug TECHNESCAN HDP contains one active pharmaceutical ingredient (API):

1	Technetium ⁹⁹ᵐTc oxidronic acid UNII H852YK87WP - OXIDRONATE DISODIUM
	Technetium ⁹⁹ᵐTc oxidronic acid is a radiopharmaceutical agent. A radiopharmaceutical is defined as a medicinal formulation containing radioisotopes that are used in major clinical areas for diagnosis and/or therapy. Technetium ⁹⁹ᵐTc oxidronic acid is indicated as a skeletal imaging agent in adults and children to delineate areas of abnormal osteogenesis, such as those that occur with metastatic bone disease, Paget’s disease, arthritic disease, osteomyelitis, and fractures.
	Read more about Technetium ⁹⁹ᵐTc oxidronic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TECHNESCAN HDP Powder for solution	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V09B	Skeleton	V Various → V09 Diagnostic radiopharmaceuticals
Discover more medicines within V09B

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1024388
ES	Centro de información online de medicamentos de la AEMPS	62198
FR	Base de données publique des médicaments	60680832
GB	Medicines & Healthcare Products Regulatory Agency	394726
HK	Department of Health Drug Office	44005
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67521001
SG	Health Sciences Authority	10712P, 12151P
US	FDA, National Drug Code	69945-091